Discounts for weight loss drugs are estimated at more than half, fueling questions about price, PBMs and coverage

Pop­u­lar weight loss drugs are like­ly be­ing dis­count­ed by half or more from their list prices, ac­cord­ing to a new study, a gap that’s ex­pect­ed to height­en ten­sions about pa­tients’ ac­cess to the prod­ucts and out-of-pock­et spend­ing.

While wide gaps be­tween a drug’s list price and what’s ac­tu­al­ly paid are com­mon, the GLP-1 drugs are unique. They’ve be­come one of the fastest-sell­ing cat­e­gories of all time, and many peo­ple are pay­ing out-of-pock­et at the much high­er list prices.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.